Johnathan Q. Trinh, MD, et al discuss a novel case of a patient with an aggressive CDKN2A-mutated spiradenocarcinoma who responded to a CDK4/6 inhibitor.
Jonathan Q. Trinh, MD
Advertisement
Articles by Jonathan Q. Trinh, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Acid Reducers, Drug-Drug Interactions, and Setting Expectations for Response
2
How Psycho-Oncology Addresses Existential Distress, Body Image, and Intimacy
3
Meaning-Centered Therapy, Psychiatry Referrals, and Humanistic Cancer Care
4
Differentiation Syndrome, Cardiac Monitoring, and Administration of Menin Inhibitors
5